» Articles » PMID: 35033959

Trends and Characteristics of Cannabis-associated Emergency Department Visits in the United States, 2006-2018

Overview
Publisher Elsevier
Specialty Psychiatry
Date 2022 Jan 16
PMID 35033959
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cannabis policies are rapidly changing in the United States, yet little is known about how this has affected cannabis-associated emergency department (ED) visits.

Methods: We studied trends in cannabis-associated ED visits and identified differences by visit characteristics. Cannabis-associated ED visits from 2006 to 2018 were identified from the Agency for Healthcare Research and Quality's Healthcare Cost and Utilization Project's (HCUP) Nationwide Emergency Department Sample (NEDS). JoinPoint analysis was used to identify trends from 2006 to 2014, prior to medical coding changes in 2015, and Z-tests were used to compare annual rate changes from 2016 to 2018. Changes in rates from 2017 to 2018 were examined by visit characteristics.

Results: From 2006-2014, the rate of cannabis-associated ED visits increased, on average, 12.1% annually (p < 0.05), from 12.3 to 34.7 visits per 100,000 population. The rate increased 17.3% from 2016 to 2017 (p < 0.05) and 11.1% from 2017 to 2018 (p < 0.05). From 2017-2018, rates of visits increased for both males (8.7%; p < 0.05) and females (15.9%; p < 0.05). Patients 0-14 years and 25 years and older had significant rate increases from 2017 to 2018 as did the Midwest region (36.8%; p < 0.05), the Northeast (9.2%; p < 0.05), and the South (4.5%; p < 0.05).

Conclusions: Cannabis-associated ED visits are on the rise and subgroups are at increased risk. Some potential explanations for increases in cannabis-associated ED visits include increased availability of cannabis products, increased use, and diversity of products available in marketplaces. Strategies are needed to prevent youth initiation, limit potentially harmful use among adults, and ensure safe storage where cannabis use is legal.

Citing Articles

Prevalence and trends of suspected cannabinoid hyperemesis syndrome over an 11-year period in Northern California: An electronic health record study.

Costales B, Lu Y, Young-Wolff K, Cotton D, Campbell C, Iturralde E Drug Alcohol Depend. 2024; 263:112418.

PMID: 39216202 PMC: 11404979. DOI: 10.1016/j.drugalcdep.2024.112418.


Substance Use Patterns and Characteristics Using Real World Data from Adolescents Assessed for Substance Use and Treatment Planning-United States, 2017-2021.

Jiang X, Guy Jr G, Schmit K, Hoots B, Roehler D, Govoni T Subst Use Misuse. 2024; 59(13):1839-1859.

PMID: 39072503 PMC: 11444876. DOI: 10.1080/10826084.2024.2383609.


An Automated "Hands-Off" Method for Sampling Mainstream Smoke from Cannabis Cigarettes.

Campbell D, Bhattarai C, Son Y, Khlystov A Toxics. 2024; 12(5).

PMID: 38787092 PMC: 11125762. DOI: 10.3390/toxics12050313.


Latent transition analysis of time-varying cannabis use motives to inform adaptive interventions.

West B, Ma Y, Lankenau S, Wong C, Bonar E, Patrick M Psychol Addict Behav. 2024; 38(7):759-771.

PMID: 38780582 PMC: 11527589. DOI: 10.1037/adb0001012.


Oral Cannabis consumption and intraperitoneal THC:CBD dosing results in changes in brain and plasma neurochemicals and endocannabinoids in mice.

Reisdorph N, Doenges K, Levens C, Manke J, Armstrong M, Smith H J Cannabis Res. 2024; 6(1):10.

PMID: 38429800 PMC: 10908076. DOI: 10.1186/s42238-024-00219-x.


References
1.
Hartman R, Brown T, Milavetz G, Spurgin A, Pierce R, Gorelick D . Cannabis effects on driving lateral control with and without alcohol. Drug Alcohol Depend. 2015; 154:25-37. PMC: 4536116. DOI: 10.1016/j.drugalcdep.2015.06.015. View

2.
Tremblay M, Baydala L, Khan M, Currie C, Morley K, Burkholder C . Primary Substance Use Prevention Programs for Children and Youth: A Systematic Review. Pediatrics. 2020; 146(3). DOI: 10.1542/peds.2019-2747. View

3.
Blanco C, Hasin D, Wall M, Florez-Salamanca L, Hoertel N, Wang S . Cannabis Use and Risk of Psychiatric Disorders: Prospective Evidence From a US National Longitudinal Study. JAMA Psychiatry. 2016; 73(4):388-95. DOI: 10.1001/jamapsychiatry.2015.3229. View

4.
Hudak M, Severn D, Nordstrom K . Edible Cannabis-Induced Psychosis: Intoxication and Beyond. Am J Psychiatry. 2015; 172(9):911-2. DOI: 10.1176/appi.ajp.2015.15030358. View

5.
Ramaekers J, Berghaus G, van Laar M, Drummer O . Dose related risk of motor vehicle crashes after cannabis use. Drug Alcohol Depend. 2004; 73(2):109-19. DOI: 10.1016/j.drugalcdep.2003.10.008. View